Skip to main content

Researchers in Danville, Bloomsburg, Lewistown and Wilkes-Barre open enrollment for national clinical trial

DANVILLE, Pa. – Geisinger has launched its participation in a new research program led by the Stanford University School of Medicine. The study, titled Stanford Technology, Analytics, and Genomics in Sleep (STAGES), is designed to provide investigators with more information about sleep and sleep disorders. Geisinger is currently accepting participants and will enroll over 11,000 individuals. 

Geisinger is conducting the research in conjunction with a cohort of other medical and sleep research facilities including Stanford School of Medicine, Mayo Clinic, St. Luke’s Hospital, MedSleep, and Bogan Sleep Consultants. The study will enroll 30,000 participants in total.

“There is so much about sleep and sleep disorders that we do not fully understand,” said Anne Marie Morse, DO, principal investigator of the study and sleep specialist at Geisinger. “Sleep impacts everything from physical and mental health to a person’s work ability and even the health of their personal relationships. This research will help doctors learn more and find better solutions to treat sleep disorders.” 

Participants must be 13 years old or older and be referred to a Geisinger Sleep Clinic. Participation includes completing questionnaires and other research activities. Participants will be seen at sleep clinics in Danville at Geisinger Medical Center, in Bloomsburg at Geisinger Bloomsburg Hospital, in Wilkes-Barre at the Geisinger South Wilkes-Barre Sleep Clinic and in Lewistown at Geisinger Lewistown Hospital. Recruitment may expand to other Geisinger locations.

For additional information or to sign up as a participant of the STAGES study, visit geisinger.org/STAGES or call 570-214-1651.

 

About Geisinger
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.

geisinger-caring-placeholder

For media inquires:

Marc Stempka
Media Specialist
Marketing & Communications

570-214-3091
mstempka@geisinger.edu